| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.1 |